| 论文题目 | 作者 | 刊物名称 | 发表年 |
|---|---|---|---|
| High titer self-propagating capsidless Chikungunya virus generated in Vero cells as a strategy for alphavirus vaccine development | Zhang YN, Zhang ZR, Li N, Pei XR, Li XD, Deng CL, Ye HQ, Zhang B. | J Virol. | 2022 |
| Stepwise Enzymatic-Dependent Mechanism of Ebola Virus Binding to Cell Surface Receptors Monitored by AFM | Zhang Q, Yang J, Tillieux S, Guo Z, Natividade RDS, Koehler M, Petitjean S, Cui Z, Alsteens D. | Nano Lett. | 2022 |
| A high-dose inoculum size results in persistent viral infection and arthritis in mice infected with chikungunya virus | Zhang Y, Yan H, Li X, Zhou D, Zhong M, Yang J, Zhao B, Fan X, Fan J, Shu J, Lu M, Jin X, Zhang E, Yan H. | PLoS Negl Trop Dis. | 2022 |
| CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity | Long Y, Sun J, Song TZ, Liu T, Tang F, Zhang X, Ding L, Miao Y, Zhu W, Pan X, An Q, Qin M, Tong X, Peng X, Yu P, Zhu P, Xu J, Zhang X, Zhang Y, Liu D, Chen B, Chen H, Zhang L, Xiao G, Zuo J, Tang W, Zhou J, Li H, Xu Z, Zheng HY, Long XY, Qin Q, Gan Y, Ren J, Huang W, Zheng YT, Jin G, Gong L. | Cell Discov. | 2022 |
| African swine fever virus I267L acts as an important virulence factor by inhibiting RNA polymerase III-RIG-I-mediated innate immunity | Ran Y, Li D, Xiong MG, Liu HN, Feng T, Shi ZW, Li YH, Wu HN, Wang SY, Zheng HX, Wang YY. | PLoS Pathog. | 2022 |
| ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants | Ou J, Zhang Y, Wang Y, Zhang Z, Wei H, Yu J, Wang Q, Wang G, Zhang B, Wang C. | Signal Transduct Target Ther. | 2022 |
| Screening of Botanical Drugs against SARS-CoV-2 Entry Reveals Novel Therapeutic Agents to Treat COVID-19 | Junyuan Cao,Yang Liu,Minmin Zhou,Siqi Dong,Yuxia Hou,Xiaoying Jia,Xiaohao Lan,Yueli Zhang,Jiao Guo,Gengfu Xiao andWei Wang | Viruses | 2022 |
| Genetic Signatures from Adaptation of Bacteria to Lytic Phage Identify Potential Agents to Aid Phage-Killing of Multidrug-Resistant Acinetobacter baumannii | Oyejobi GK, Xiong D, Shi M, Zhang X, Yang H, Xue H, Ogolla F, Wei H. | J Bacteriol. | 2022 |
| Circulation, genomic characteristics, and evolutionary dynamics of class I Newcastle disease virus in China | Jia L, Liang B, Wu K, Wang R, Liu H, Di Liu, Chen Q. | Virulence | 2022 |
| Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2 | Dai W, Jochmans D, Xie H, Yang H, Li J, Su H, Chang D, Wang J, Peng J, Zhu L, Nian Y, Hilgenfeld R, Jiang H, Chen K, Zhang L, Xu Y, Neyts J, Liu H. | J Med Chem. | 2022 |
| Evaluating the virucidal activity of four disinfectants against SARS-CoV-2 | Huang Y, Xiao S, Song D, Yuan Z. | Am J Infect Control. | 2022 |
| Covalently Engineered Protein Minibinders with Enhanced Neutralization Efficacy against Escaping SARS-CoV-2 Variants | Han Y, Yang Z, Hu H, Zhang H, Chen L, Li K, Kong L, Wang Q, Liu B, Wang M, Lin J, Chen PR. | J Am Chem Soc. | 2022 |
| Different pathogenesis of SARS-CoV-2 Omicron variant in wild-type laboratory mice and hamsters | Zhang YN, Zhang ZR, Zhang HQ, Li N, Zhang QY, Li XD, Deng CL, Deng F, Shen S, Zhu B, Zhang B. | Signal Transduct Target Ther. | 2022 |
| HAMdetector: A Bayesian regression model that integrates information to detect HLA-associated mutations | Habermann D, Kharimzadeh H, Walker A, Li Y, Yang R, Kaiser R, Brumme ZL, Timm J, Roggendorf M, Hoffmann D. | Bioinformatics | 2022 |
| A protein vaccine with Alum/c-GAMP/poly(I:C) rapidly boosts robust immunity against SARS-CoV-2 and variants of concern | Zhang RY, Yin XG, Zhou SH, Zhang HW, Lu J, He CB, Wang J, Wen Y, Li YT, Liu YL, Feng RR, Ding D, Wei HW, Gong R, Yang GF, Guo J. | Chem Commun (Camb). | 2022 |
| A point-of-care SARS-CoV-2 test based on reverse transcription loop-mediated isothermal amplification without RNA extraction with diagnostic performance same as RT-PCR | Odiwuor N, Xiong J, Ogolla F, Hong W, Li X, Khan FM, Wang N, Yu J, Wei H. | Anal Chim Acta. | 2022 |
| Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks | Nyaruaba R, Mwaliko C, Dobnik D, Neu？il P, Amoth P, Mwau M, Yu J, Yang H, Wei H. | Clin Microbiol Rev. | 2022 |
| Structural and Biochemical Basis for Development of Diketo Acid Inhibitors Targeting the Cap-Snatching Endonuclease of the Ebinur Lake Virus (Order: Bunyavirales) | Kuang W, Zhang H, Cai Y, Zhang G, Deng F, Li H, Zhou Y, Wang M, Gong P, Guo Y, Hu Z. | J Virol. | 2022 |
| ACE2-independent infection of T lymphocytes by SARS-CoV-2 | Shen XR, Geng R, Li Q, Chen Y, Li SF, Wang Q, Min J, Yang Y, Li B, Jiang RD, Wang X, Zheng XS, Zhu Y, Jia JK, Yang XL, Liu MQ, Gong QC, Zhang YL, Guan ZQ, Li HL, Zheng ZH, Shi ZL, Zhang HL, Peng K, Zhou P. | Signal Transduct Target Ther. | 2022 |
| Tracking the Replication-Competent Zika Virus with Tetracysteine-Tagged Capsid Protein in Living Cells | Li S, Wang D, Ghulam A, Li X, Li M, Li Q, Ma Y, Wang L, Wu H, Cui Z, Zhang XE. | J Virol. | 2022 |
科研成果